Arizona State Board of Pharmacy

Controlled Substances Prescription Monitoring Program

Latest News

The Controlled Substances Prescription Monitoring Program (CSPMP) is a program developed to promote the public health and welfare by detecting diversion, abuse, and misuse of prescription medications classified as controlled substances under the Arizona Uniform Controlled Substances Act. To learn more about Arizona's Controlled Substances Prescription Monitoring Program history, click here.

 

 

Registration

Step 1 for Medical Practitioners (not pharmacists or delegates - see below)

A.R.S. § 36-2606 requires each medical practitioner who is licensed under Title 32 and who possesses a DEA license to register with the CSPMP.  Each DEA license should have an associated registration.  There is NO fee to the practitioner for this registration. This registration includes: MD, DO, DDS, DMD, DPM, HMD, PA, NP, ND, OD, and DVM.

Residents may register using the hospital DEA number and appropriate suffix.

Register now

 

Accessing the Data

Step 1 for Pharmacists & Delegates OR Step 2 for Medical Practitioners

The Arizona State Board of Pharmacy Controlled Substances Prescription Monitoring Program (CSPMP) grants system access accounts to practitioners and pharmacists so that they may look up, view, and print controlled substance dispensing information on their specific patients directly via user name and password. Access is granted to individuals only—not to clinics, hospitals, pharmacies, or any other health care facility.

 

To register for access to the database (medical practitioners must have completed Step 1 Registration)

Pharmacists click here

Prescriber Licensed Delegates click here

Prescriber Unlicensed Delegates click here

Pharmacist Licensed Delegates click here

Medical Practitioners click here

Contact Us

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.
Subscribe to Arizona State Board of Pharmacy RSS